Skip to main content

Find Clinical Trials

Home
Conditions
Recurrent Mucoepidermoid Carcinoma of the Oral Cavity

Clinical trial condition

Recurrent Mucoepidermoid Carcinoma of the Oral Cavity

Explore clinical trials studying Recurrent Mucoepidermoid Carcinoma of the Oral Cavity. Study availability and eligibility vary by location and protocol.

15 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Recurrent Mucoepidermoid Carcinoma of the Oral Cavity trial results

Completed

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

NCT00004074

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +257 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer

NCT00023959

Conditions: Carcinoma, Carcinoma, Squamous Cell, Cranial Nerve Diseases, +75 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

View Trial Details

Completed

Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction

NCT00030498

Conditions: Adenocarcinoma, Adenoma, Adnexal Diseases, +185 more
Locations: Cancer and Leukemia Group B Chicago, Illinois, United States

View Trial Details

Completed

Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer

NCT00068497

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +132 more
Locations: Southwest Oncology Group San Antonio, Texas, United States

View Trial Details

Completed

Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer

NCT01637194

Conditions: Carcinoma, Carcinoma, Squamous Cell, Colonic Diseases, +81 more
Locations: Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details